Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refra...
Q2 2026
May 18, 2026
Q1 2026
Feb 13, 2026
FY 2025
Dec 23, 2025
Q4 2025
Q3 2025
Aug 12, 2025